ArticleCancer management and research2022

A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma.

Qingqing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.